Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

Details for Australian Patent Application No. 2009221328 (hide)

Owner Merck Patent GmbH

Inventors Botton, Gerard; Charon, Christine; Elbawab, Samer; Kergoat, Micheline

Agent Davies Collison Cave

Pub. Number AU-A-2009221328

PCT Pub. Number WO2009/109259

Priority 08004193.2 05.03.08 EP

Filing date 15 January 2009

Wipo publication date 11 September 2009

International Classifications

C07D 241/18 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

28 October 2010 PCT application entered the National Phase

  PCT publication WO2009/109259 Priority application(s): WO2009/109259

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221339-5-Oxo-2, 3,4,5-tetrahydro-benzo[b]oxepine-4-car boxylic acid amides and 2,3-Dihydro-benzo[b]oxepine-4-carboxy lic acid amides for treatment and prevention of Diabetes Typ 1 and 2

2009221327-Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes